Explore Drug Effects Against SARS-CoV-2 Phenotypic Screening

COVID-19 Drug Discovery leveraging Phenotypic Screening using Artificial Intelligence.

This blog page should redirect to the SARS-CoV-2 Interactive Blog where you can explore Contingent-AI™ HTS data results from BioSymetrics   If not, please click and follow the link below:

https://covid.blog.biosymetrics.com/

Previous
Previous

BioSymetrics Joins Accenture’s INTIENT Network

Next
Next

Predicting Mechanism of Action Using AI - Webinar